Eagle Health Investments LP Alnylam Pharmaceuticals, Inc. Transaction History
Eagle Health Investments LP
- $407 Million
- Q4 2024
A detailed history of Eagle Health Investments LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Eagle Health Investments LP holds 76,256 shares of ALNY stock, worth $19.1 Million. This represents 4.41% of its overall portfolio holdings.
Number of Shares
76,256
Previous 76,256
-0.0%
Holding current value
$19.1 Million
Previous $21 Million
14.46%
% of portfolio
4.41%
Previous 3.98%
Shares
11 transactions
Others Institutions Holding ALNY
# of Institutions
667Shares Held
112MCall Options Held
839KPut Options Held
771K-
Capital World Investors Los Angeles, CA16.6MShares$4.16 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.19 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.39 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.75 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.1 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $30.8B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...